Pharmacology, Toxicology and Pharmaceutical Science
Neurilemoma
100%
Neoplasm
58%
Merlin
56%
Mitogen Activated Protein Kinase 3
25%
Selumetinib
24%
Meningioma
21%
Protein MDM2
21%
Protein P53
21%
Neurofibromatosis Type 2
20%
Focal Adhesion Kinase
19%
Mitogen Activated Protein Kinase
13%
Nilotinib
13%
Phosphotransferase
13%
Protein Tyrosine Kinase
13%
Tumor Suppressor Protein
11%
Growth Factor
10%
Guanosine Triphosphatase
10%
Platelet Derived Growth Factor Beta Receptor
10%
Somatomedin Binding Protein 1
10%
Orexin
10%
Fibulin
10%
Biological Marker
10%
Imatinib
8%
Ependymoma
7%
Platelet Derived Growth Factor
7%
Malignant Neoplasm
6%
Sorafenib
6%
Western Blot
5%
Integrin
5%
Platelet Derived Growth Factor Receptor
5%
Medicine and Dentistry
Neurinoma
99%
Merlin
71%
Neoplasm
49%
Protein P53
21%
Protein MDM2
21%
Focal Adhesion Kinase
20%
Mitogen Activated Protein Kinase 3
18%
Phosphotransferase
13%
Neurofibromatosis Type II
12%
Mitogen-Activated Protein Kinase
12%
Tumor Suppressor Protein
12%
Selumetinib
11%
Somatomedin
10%
Guanosine Triphosphatase
10%
Growth Factor
10%
Adhesive Agent
10%
Somatomedin Binding Protein 1
10%
Meningioma
9%
Cell-Matrix Adhesion
9%
Nervous System
8%
Cell Proliferation
7%
Ependymoma
7%
In Vitro
7%
Somatomedin C Receptor
6%
Schwann Cell
6%
Cell Adhesion
5%
Platelet Derived Growth Factor Receptor
5%
Integrin
5%
Neuroscience
Merlin
83%
Schwannoma
71%
Neurofibromatosis Type II
22%
Protein MDM2
21%
P53
21%
Focal Adhesion Kinase
14%
Somatomedin
10%
Orexin
10%
Fatty Acids
10%
Contact Inhibition
10%
Catenin
10%
Meningioma
10%
Insulin-Like Growth Factor 1 Receptor
8%
Extracellular Matrix
7%
Ependymoma
7%
Nervous System
6%
Feeding Behavior
6%
Platelet-Derived Growth Factor Receptor
6%
Central Nervous System
5%